#mentalhealth #PsychedelicInspiredMedicine #MindMed #MM120 #anxietydisorder #GeneralisedAnxietyDisorder #GAD #GADtreatment #MM120ODT #lysergideDtartrate #LSD #clinicaltrialparticipants #Voyagestudy #GADpatients #BreakthroughTherapyDesignation #Panoramastudy
pharmatimes.com/news/mindmed...
pharmatimes.com/news/mindmed...
MindMed begins phase 3 study of MM120 for anxiety disorder - PharmaTimes
First patient dosed in landmark trial for GAD treatment
pharmatimes.com
December 19, 2024 at 11:53 AM